Tata Chemicals Ltd

Q3 FY25Chemicals & Petrochemicals

Tata Chemicals Q3 FY25 earnings call: Revenue & Margins

Q3 FY25 earnings call: what management guided on revenue, margins and order book.

Price₹627

Market cap₹17.0K Cr

Updated23 Aug 2026

Read5 min read

The short version

India and Asia markets are expected to continue growing, with India fully servicing its market via the new Mithapur plant and additional volumes from Kenya. - U.S. Tata Chemicals expects market pricing to remain range-bound and unsustainable for the next 3-6 months, limiting near-term margin improvement. - Growth outlook is positive for India and Asia; U.S.

From Tata Chemicals Ltd's Q3 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

India and Asia markets are expected to continue growing, with India fully servicing its market via the new Mithapur plant and additional volumes from Kenya.
U.S. sales volumes are expected to remain steady or increase sequentially, with exports to Southeast Asia rising.
Western Europe is facing a slight decline in demand; however, the U.S. economy is growing, supporting stable demand.
Pricing is expected to remain stable or slightly lower for the next 3-6 months due to supply-demand imbalance.
Capacity expansions in India, Kenya, and the U.S. are planned or underway in phases to support volume growth while managing cash flows.

2 more points management made on revenue & sales performance

Profitability & Margins

Tata Chemicals expects market pricing to remain range-bound and unsustainable for the next 3-6 months, limiting near-term margin improvement.
Growth outlook is positive for India and Asia; U.S. economy growth supports potential soda ash demand, while Western Europe is slightly declining.
Company plans calibrated expansion in U.S., Kenya, and India, with phasing of 1-million-ton capacity addition over 3-4 years to manage cash flow and returns.
Specialty products business to scale up capacity to improve margins, with focus on nutraceuticals and silica.
Cessation of UK soda ash plant is part of strategy to run sustainable units and deleverage; UK units expected to manage debt via cash earnings.

2 more points management made on profitability & margins

See what Tata Chemicals Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Tata Chemicals is progressing brownfield expansions with planned capacity additions:
U.S.: 400,000 tons expansion, possibly phased in two steps (2,000 and 3,000 or entire 5,000 tons).
Kenya: 300,000 tons planned, with an immediate 50,000-ton phase and further steps of 50,000 or 100,000 tons.
India: 300,000 tons planned as a single phase.
CAPEX timeline is roughly 3 years but may extend to 4 years depending on phasing.
The company is calibrating CAPEX based on market conditions and expected returns (aims for 20% IRR).
Brownfield expansions help manage cash flows and enhance returns since fixed costs are covered.
Additional investment of £60 million planned in UK for bicarbonate and salt businesses.

2 more points management made on capital expenditure plans

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

5x potential

1Shiv Texchem Ltd₹265 Cr

Rev 1Mar 2

2Solar Industries₹1.8L Cr

Rev 2Mar 1

3₹1.7K Cr

Rev 2Mar 1

4₹4.8K Cr

Rev 2Mar 3

5₹3.7K Cr

Rev 3Mar 1

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

Tata Chemicals is calibrating its CAPEX plans to match cash flows and market conditions, emphasizing phased brownfield expansions.
Current CAPEX includes Kenya (50,000 tons) addition and possible phased increases in the U.S. and India.
No major immediate CAPEX beyond the ongoing expansions, except a £60 million investment in bicarbonate and salt business in the UK.
Debt has increased mainly due to working capital timing issues; long-term debt is stable or reducing with repayments underway.
The UK operations are expected to manage their debt through cash earnings.

2 more points management made on fundraising & capital structure

See what Tata Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript from the Tata Chemicals Q3FY25 earnings call does not explicitly mention current or expected order book or pending orders. However, relevant insights on orders and capacity utilization include: - Specialty segment production at 80-85% capacity; fuller output expected by Q4 for Nutra and Silica plants. - Contracting in the U.S. is mostly complete, with minor quantities pending. - Indian contracts largely done for the quarter or half-year. - Growth in volumes expected in India and U.S., with stable to slightly lower pricing.

2 more points management made on order book & pipeline

Tata Chemicals Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹3.4K Cr, net loss ₹2.1K Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Tata Chemicals's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Laxmi Organic (Q3 FY25)
Specialty business pipeline remains strong with 11+ products, 60% fluoro-heavy, 40% other derivatives; focus on commercialization and capex for growth (Page…
Rain Industries (Q3 FY25)
. Key concall takeaways from Rain Industries's Q3 FY25 earnings call — and how it ranks against sector peers.
Archean Chemical (Q3 FY25)
. Key concall takeaways from Archean Chemical Industries Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.
Aether Industri. (Q3 FY25)
Site 3+ and 3++ expansion underway with potential revenue of INR 300 crores combined. Key concall takeaways from Aether Industries Ltd's Q3 FY25 earnings call…

Compare:vs Solar Industries vs Pidilite Inds.vs Gujarat Fluoroch

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Tata Chemicals Ltd Q3 FY25 results?

What is Tata Chemicals Ltd share price analysis?

Tata Chemicals Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹16,971 Cr. Investors should review the full earnings analysis for detailed insights.

Is Tata Chemicals Ltd planning capital expenditure?

Tata Chemicals is progressing brownfield expansions with planned capacity additions: - U.S.: 400,000 tons expansion, possibly phased in two steps (2,000 and 3,000 or entire 5,000 tons). - Kenya: 300,000 tons planned, with an immediate 50,000-ton phase and further steps of 50,000 or 100,000 tons. - India: 300,000 tons planned as a single phase. - CAPEX timeline is roughly 3 years but may extend to 4 years depending on phasing. - The company is calibrating CAPEX based on market conditions and expected returns (aims for 20% IRR). - Brownfield expansions help manage cash flows and enhance returns since fixed costs are covered. - Additional investment of £60 million planned in UK for bicarbonate and salt businesses. - No major new CAPEX beyond these expansions currently planned; focus is on sustainable operations and deleveraging. - Decision on U.S.

Keep Tata Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.